Skip to search formSkip to main contentSkip to account menu

Vumon

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Podophyllum hexandrum Royle is known for its vast medicinal properties, particularly anticancer. It contains higher amount of… 
2012
2012
In order to tackle the problems on low water solubility of teniposide, involvement of toxic surfactant in its injection, and the… 
Review
2004
Review
2004
SummaryThe unique biological properties and therapeutic efficacy of the podophyllotoxin derivatives, Vumon (VM26, teniposide) and… 
Highly Cited
2001
Highly Cited
2001
Acute tumour‐lysis syndrome (ATLS) is a frequently fatal complication after cytoreductive leukaemia therapy. Lactic acidosis is… 
1997
1997
Abstract After a pre-operative 1-h i.v infusion of 150 mg/m2 of teniposide (Vumon; VM26), the drug levels were determined in… 
1997
1997
A total of 332 patients with advanced non-small-cell lung cancer were randomized by the European Organization for Research and… 
1997
1997
During 5 years from September 1991 to September 1996, 93 patients (pts) with acute lymphoblastic leukemia (ALL): 45 girls and 48… 
1995
1995
Liposomes are concentrated in the mononuclear phagocytic system in vivo and may therefore be of value as carriers of drugs when… 
Highly Cited
1986
Highly Cited
1986
Teniposide, VM-26 (Vumon), was administered in a dose of 60 mg/m2 on days 1 to 5 every third week to 36 patients with…